1Kochhar DM. Studies of vitamin A-induced teratogenesis: effects onembryonic mesenchyme and epithelium, and on incorporation of H3-thymidine. Teratology, 1968,1(3): 299-310.
2Acloque H, Adams MS, Fishwick K, et al. Epithelial-mesenchymaltransitions: the importance of changing cell state in development anddisease. J Clin Invest, 2009,119(6): 1438-1449.
3Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer JClin, 2013, 63(1): 11-30.
4Denlinger CE, Ikonomidis JS, Reed CE, et al. Epithelial to mesenchymaltransition: the doorway to metastasis in human lung cancers. J ThoracCardiovasc Surg, 2010, 140(3): 505-513.
5Hugo H, Ackland ML, Blick T, et al. Epithelial--mesenchymal andmesenchymal-epithelial transitions in carcinoma progression. J CellPhysiol, 2007, 213(2): 374-383.
6Singh A, Settleman J. EMT, cancer stem cells and drug resistance: anemerging axis of evil in the war on cancer. Oncogene, 2010, 29(34):4741-4751.
7Xie L, Law BK, Chytil AM, et al. Activation of the Erk pathway is requiredfor TGF-beta 1 -induced EMT in vitro. Neoplasia, 2004, 6(5): 603-610.
8Bhangu A, Wood G, Mirnezami A, et al Epithelial mesenchymal transitionin colorectal cancer: Seminal role in promoting disease progression andresistance to neoadjuvant therapy. Surg Oncol, 2012, 21(4): 316-323.
9Katoh M. Epithelial-mesenchymal transition in gastric cancer (Review). IntJ Oncol, 2005,27(6): 1677-1683.
10Trimboli AJ, Fukino K, de Bruin A, et al. Direct evidence for epithelial-mesenchymal transitions in breast cancer. Cancer Res, 2008, 68(3):937-945.
